Australia Biopharmaceutical Third-party Logistics Market Size & Outlook
Australia biopharmaceutical third-party logistics market, 2018-2030 (US$M)
Related Markets
Australia biopharmaceutical third-party logistics market highlights
- The Australia biopharmaceutical third-party logistics market generated a revenue of USD 3,364.9 million in 2024 and is expected to reach USD 5,023.8 million by 2030.
- The Australia market is expected to grow at a CAGR of 7% from 2025 to 2030.
- In terms of segment, non-cold chain logistics was the largest revenue generating supplychain in 2024.
- Cold Chain Logistics is the most lucrative supplychain segment registering the fastest growth during the forecast period.
Biopharmaceutical third-party logistics market data book summary
| Market revenue in 2024 | USD 3,364.9 million |
| Market revenue in 2030 | USD 5,023.8 million |
| Growth rate | 7% (CAGR from 2025 to 2030) |
| Largest segment | Non-cold chain logistics |
| Fastest growing segment | Cold Chain Logistics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cold Chain Logistics, Non-cold Chain Logistics |
| Key market players worldwide | DHL Group, SF Express, United Parcel Service Inc Class B, AmerisourceBergen Drug Corporation, DB Schenker, Kuehne + Nagel International AG, Kerry Logistics Network Ltd, Agility |
Other key industry trends
- In terms of revenue, Australia accounted for 2.3% of the global biopharmaceutical third-party logistics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan biopharmaceutical third-party logistics market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 8,965.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical Third-party Logistics Market Scope
Biopharmaceutical Third-party Logistics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia biopharmaceutical third-party logistics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical third-party logistics market will help companies and investors design strategic landscapes.
Non-cold chain logistics was the largest segment with a revenue share of 83.5% in 2024. Horizon Databook has segmented the Australia biopharmaceutical third-party logistics market based on cold chain logistics, non-cold chain logistics covering the revenue growth of each sub-segment from 2018 to 2030.
Australia biopharmaceutical third party logistics market accounted for 14.1% market share in 2020 in the Asia Pacific market. According to the World Bank, the Logistics Performance Index (LPI) score of Australia was 3.75 in 2018.
For instance, according to OECD, an estimated 216,247 million tonne-km of freight transport took place in the country in 2018. DHL and Linfox have undertaken the supply and distribution of COVID-19 vaccine in Australia.
Reasons to subscribe to Australia biopharmaceutical third-party logistics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia biopharmaceutical third-party logistics market databook
-
Our clientele includes a mix of biopharmaceutical third-party logistics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia biopharmaceutical third-party logistics market , including forecasts for subscribers. This country databook contains high-level insights into Australia biopharmaceutical third-party logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia biopharmaceutical third-party logistics market size, by supplychain, 2018-2030 (US$M)
Australia Biopharmaceutical Third-party Logistics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
